Bill

Bill > S2465


US S2465

US S2465
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018


summary

Introduced
02/28/2018
In Committee
07/25/2018
Crossed Over
10/16/2018
Passed
12/13/2018
Dead
Signed/Enacted/Adopted
12/18/2018

Introduced Session

115th Congress

Bill Summary

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018

AI Summary

This bill amends the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program and provide for sickle cell disease research, surveillance, prevention, and treatment. Specifically, it authorizes the Secretary to award grants to collect and maintain data on heritable blood disorders like sickle cell disease, conduct public health activities to improve health outcomes and access to quality care, and support state health departments and regional laboratories in testing and identifying these conditions. The bill also reauthorizes and modifies the existing sickle cell disease prevention and treatment demonstration program, extending it until 2023. Additionally, the bill expresses the Sense of the Senate that further research should be undertaken to expand the understanding of the causes of, and find cures for, heritable blood disorders, including sickle cell disease.

Committee Categories

Health and Social Services

Sponsors (7)

Last Action

Became Public Law No: 115-327. (on 12/18/2018)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...